A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus

NCT03445065 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DEVICE: Eversense XL CGM System
DEVICE: Usual SMBG or FGM device used by participants

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]